Dact3 - dishevelled-binding antagonist of beta-catenin 3

Predicted to enable several functions, including delta-catenin binding activity; identical protein binding activity; and protein kinase C binding activity. Predicted to be involved in negative regulation of canonical Wnt signaling pathway and negative regulation of cell growth. Predicted to act upstream of or within negative regulation of epithelial to mesenchymal transition. Predicted to be active in cytoplasm. Orthologous to human DACT3 (dishevelled binding antagonist of beta catenin 3). [provided by Alliance of Genome Resources, Apr 2022]